Investing in Disruptive Tech: Capturing the Growth of Robotics, AI & Health Tech
For those interested in investing in disruptive technologies, the path can be both rewarding and complex. Capturing the growth of robotics, AI, and healthcare tech requires in-depth research paired with a diversified approach. In this webinar, you’ll learn about the companies at the forefront of this technology revolution and how to gain exposure with three unique, global portfolios.
Join ROBO Global for a discussion on the best ways for investors to capitalize on the robotics, AI, and healthcare tech revolution.
- Why smart investors should incorporate disruptive technologies in their portfolios to prepare for the future.
- A concrete understanding of the ROBO Global innovation indices: HTEC, THNQ and ROBO.
- How the pandemic has paved a path to increased investment and innovation in healthcare.
- Capturing the growth of robotics, AI, and healthcare tech
- The companies at the forefront of this technology revolution
Event Recording
Investing in Disruptive Tech: Capturing the Growth of Robotics, AI & Health Tech
Speakers
William Studebaker
- Title
- President & CIO @
- Company
- ROBO Global
- Role
- Speaker
Bill Studebaker joined the ROBO Global team in 2015 after more than 20 years in capital markets and investment management. For more than a decade, he served as a portfolio manager at Apex Capital where he covered industrials and the economies of supply chain management. Earlier in his career, he held a number of positions at Merrill Lynch, including as a trader on the floor of the New York Stock Exchange and as a director in institutional equity sales, and he was an analyst in the structured finance group of Cargill. Bill received his BA in Political Science and International Relations (double major) from the University of Wisconsin-Madison.
Nina Deka
- Title
- Senior Research Analyst
- Role
- Speaker
Nina Deka brings nearly two decades of healthcare industry and investment research experience to the ROBO Global research team. Before joining ROBO Global in 2019, Nina spent six years as a research analyst on the sell-side at Piper Jaffray where she covered healthcare IT and services, focusing on themes such as telehealth and data analytics. Prior to transitioning to financial services, Nina spent 13+ years in the healthcare sector. More recently, she was a sales consultant at Becton Dickinson, where she helped some of the nation’s largest health systems improve patient outcomes and efficiency, while increasing sales for BD devices. She worked at Cardinal Health in its Financial Development Program, and held positions that spanned sales, corporate finance, and post-merger integration across Cardinal’s global manufacturing and distribution businesses. Nina received her BBA in Finance from the University of Iowa and an MBA from Cornell University. She also holds FINRA licenses series 7, 63, 86, and 87.
About
ROBO Global
ROBO Global is an index, advisory, and research company wholly focused on helping investors capture the unique opportunities of fast-growing robotics, artificial intelligence, and healthcare technology companies around the world.